Article By:
Scott Matusow
Monday, November 24, 2014 12:28 PM EDT
Cempra Pharmaceuticals expects top-line data release for community acquired bacterial pneumonia by the end of Q1'15.
With the very recent Tetraphase acquisition rumor buzz, Cempra is certain to join the acquisition buzz fray if its data release proves positive.